CorralRosales is built on one of the most successful trademark and patent prosecution and enforcement practices in Latin America. In fact, we are the number one patent and trademark filer in Ecuador.
We consistently rank in the higher echelon of intellectual property legal service providers, as recognized by Chambers & Partners, The Legal500, WTR1000 and many others, being a reflection of our high quality IP legal solutions.
Maria Cecilia Romoleroux, with decades of experience in intellectual property, leads of our team of IP practitioners. Her passion and knowledge in all matters related to IP is exemplified in her relentless commitment to our clients and the industry at large. Clients can rest assured that their matters are handled with the utmost competence.
We are entrusted by Ecuadorian firms and multinationals of all sizes to provide them with comprehensive portfolio management, strategies and solutions to all of their intellectual property challenges in Ecuador and throughout Latin America.
Our firm is also committed to anti-counterfeiting and takes extra measures to monitor and enforce exclusive trademark and patent rights, even going so far as to create robust anti-counterfeiting plans, customized for our clients.
We have one of the only regulatory practices in Ecuador. When it comes to being able to successfully maneuver your way through the bureaucracy necessary to actually operate, advertise, market and sell in Ecuador, we do that. Our regulatory practice works hand in hand with our IP department making certain that all requirements are met and communicated timely. Efficiently.
The key to our firm’s achievements stem from our ability to promptly deliver the highest quality results that clients can depend on. We do it with guaranteed response times, accuracy and precision.
The cannabis and hemp industry is an emerging new industry in Ecuador with the Reform of the Criminal Law, enacted on June 21st, 2020. Included among the reforms is the decriminalization of possession of drugs containing cannabis or derivatives as their active ingredient for therapeutic, palliative, or medicinal use, or for the practice of alternative medicine. In addition, the Law of Control and Prevention of the use of Drugs has been amended, excluding non-psychoactive or hemp cannabis from control,…
In the 1st Supplement of the Official Gazette No. 107 of December 24, 2019, the Reform of the Criminal Law was published, which will enter into force in June 21, 2020. Included among the reforms, is the decriminalization of possession of drugs that contain cannabis or derivatives as their active ingredient for therapeutic, palliative or medicinal ends, or for the practice of alternative medicine. In addition, the Law of Control and Prevention of the use of Drugs has been amended,…
Biosimilars and biologics in Ecuadorian pharma – a comprehensive legal overview. Prepared in association with Corral Rosales, a leading global law firm, this is an extract from The Pharma Legal Handbook: Ecuador, available to purchase here for GBP 75. 1. Are biosimilar medicines considered the same as generic medicines in your country? No, the generic term is used only for chemical synthesis medicines and the term biosimilar is used for medicines of biological origin. The biosimilar medicine is similar…